Atlas Trials

Add Glucokinase Activator to Target A1c

Clinical trial NCT02405260 · COMPLETED

Trial details

NCT number
NCT02405260
Sponsor
vTv Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2015-03-01
Primary completion
2016-07-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.